Emeren Group Ltd (NYSE:SOL – Free Report) – Equities researchers at HC Wainwright upped their FY2025 earnings estimates for Emeren Group in a research report issued on Friday, November 15th. HC Wainwright analyst A. Dayal now expects that the semiconductor company will post earnings per share of $0.56 for the year, up from their prior estimate of $0.54. HC Wainwright currently has a “Buy” rating and a $7.00 price objective on the stock. The consensus estimate for Emeren Group’s current full-year earnings is $0.33 per share.
A number of other equities analysts have also recently commented on the company. Roth Mkm reiterated a “buy” rating and issued a $3.00 target price on shares of Emeren Group in a report on Wednesday, August 21st. StockNews.com lowered Emeren Group from a “hold” rating to a “sell” rating in a research note on Wednesday, November 13th. Three investment analysts have rated the stock with a sell rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $3.83.
Emeren Group Stock Down 4.5 %
SOL opened at $1.91 on Monday. The company has a quick ratio of 4.27, a current ratio of 4.27 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $97.91 million, a PE ratio of -14.69 and a beta of 1.73. Emeren Group has a 52 week low of $1.41 and a 52 week high of $3.00. The firm has a 50-day simple moving average of $2.42 and a two-hundred day simple moving average of $1.98.
Emeren Group (NYSE:SOL – Get Free Report) last posted its quarterly earnings data on Tuesday, August 20th. The semiconductor company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.06). The company had revenue of $30.06 million during the quarter, compared to analysts’ expectations of $21.10 million. Emeren Group had a negative return on equity of 2.05% and a negative net margin of 7.14%. During the same quarter last year, the company earned $0.14 earnings per share.
Insider Activity
In other news, Chairman Shah Capital Management purchased 26,843 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were bought at an average cost of $1.83 per share, with a total value of $49,122.69. Following the purchase, the chairman now directly owns 18,655,151 shares of the company’s stock, valued at approximately $34,138,926.33. This trade represents a 0.14 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 37.31% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of SOL. Long Run Wealth Advisors LLC bought a new stake in Emeren Group during the third quarter valued at $28,000. Mercer Global Advisors Inc. ADV increased its holdings in shares of Emeren Group by 160.9% during the second quarter. Mercer Global Advisors Inc. ADV now owns 47,809 shares of the semiconductor company’s stock valued at $72,000 after purchasing an additional 29,484 shares during the period. Finally, XTX Topco Ltd bought a new position in shares of Emeren Group in the third quarter valued at approximately $88,000. Institutional investors and hedge funds own 44.08% of the company’s stock.
Emeren Group Company Profile
Emeren Group Ltd, together with its subsidiaries, develops, builds, and sells solar power projects. It owns and operates 3-gigawatt pipeline of projects and independent power producer assets, as well as a 10-gigawatt pipeline of storage pipeline. The company develops community solar gardens; and sells project rights.
Read More
- Five stocks we like better than Emeren Group
- How to Invest in Blue Chip Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Emeren Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emeren Group and related companies with MarketBeat.com's FREE daily email newsletter.